ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 229 filers reported holding ARRAY BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,767,000 | +117.9% | 72,500 | 0.0% | 0.65% | +29.8% |
| Q4 2018 | $811,000 | -91.8% | 72,500 | -91.4% | 0.50% | -89.2% |
| Q3 2018 | $9,844,000 | -15.5% | 844,500 | +21.6% | 4.68% | +4.6% |
| Q2 2018 | $11,647,000 | -16.1% | 694,500 | -18.4% | 4.47% | -17.5% |
| Q1 2018 | $13,888,000 | +127.2% | 851,500 | +78.3% | 5.42% | +151.4% |
| Q4 2017 | $6,112,000 | +100.8% | 477,500 | +92.9% | 2.16% | +81.9% |
| Q3 2017 | $3,044,000 | +13.5% | 247,500 | -22.8% | 1.18% | +16.3% |
| Q2 2017 | $2,681,000 | +286.9% | 320,744 | +313.9% | 1.02% | +284.5% |
| Q1 2017 | $693,000 | +21.4% | 77,500 | +19.2% | 0.26% | +3.1% |
| Q4 2016 | $571,000 | – | 65,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |